Loading clinical trials...
Loading clinical trials...
This is a randomized, double-blind, parallel group, placebo-controlled, multicenter study to investigate the safety, tolerability, and efficacy of VK5211 after 12 weeks of treatment. Males and female...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Viking Therapeutics, Inc.
NCT06565910 · Femoral Neck Fractures, Femur Head Necrosis, and more
NCT07432737 · Hip Fractures
NCT06521671 · Femoral Neck Fractures, Internal Fixation; Complications, and more
NCT06278987 · Hip Fractures
NCT04743765 · Hip Fractures, Myocardial Injury
Duurga Clinical Service
Yorba Linda, California
Orthopedic Research Institute
Boynton Beach, Florida
Infinite Clinical Research
Doral, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions